Satoh Kimio, Kagaya Yutaka, Nakano Makoto, Ito Yoshitaka, Ohta Jun, Tada Hiroko, Karibe Akihiko, Minegishi Naoko, Suzuki Norio, Yamamoto Masayuki, Ono Masao, Watanabe Jun, Shirato Kunio, Ishii Naoto, Sugamura Kazuo, Shimokawa Hiroaki
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Circulation. 2006 Mar 21;113(11):1442-50. doi: 10.1161/CIRCULATIONAHA.105.583732. Epub 2006 Mar 13.
Recent studies have suggested that endogenous erythropoietin (Epo) plays an important role in the mobilization of bone marrow-derived endothelial progenitor cells (EPCs). However, it remains to be elucidated whether the Epo system exerts protective effects on pulmonary hypertension (PH), a fatal disorder encountered in cardiovascular medicine.
A mouse model of hypoxia-induced PH was used for study. We evaluated right ventricular systolic pressure, right ventricular hypertrophy, and pulmonary vascular remodeling in mice lacking the Epo receptor (EpoR) in nonerythroid lineages (EpoR(-/-) rescued mice) after 3 weeks of exposure to hypoxia. Those mice lack EpoR in the cardiovascular system but not in the hematopoietic system. The development of PH and pulmonary vascular remodeling were accelerated in EpoR(-/-) rescued mice compared with wild-type mice. The mobilization of EPCs and their recruitment to the pulmonary endothelium were significantly impaired in EpoR(-/-) rescued mice. By contrast, reconstitution of the bone marrow with wild-type bone marrow cells ameliorated PH in the EpoR(-/-) rescued mice. Hypoxia enhanced the expression of EpoR on pulmonary endothelial cells in wild-type but not EpoR(-/-) rescued mice. Finally, hypoxia activated endothelial nitric oxide synthase in the lungs in wild-type mice but not in EpoR(-/-) rescued mice.
These results indicate that the endogenous Epo/EpoR system plays an important role in the recruitment of EPCs and prevents the development of PH during chronic hypoxia in mice in vivo, suggesting the therapeutic importance of the system for the treatment of PH.
最近的研究表明,内源性促红细胞生成素(Epo)在骨髓来源的内皮祖细胞(EPCs)动员中起重要作用。然而,Epo系统是否对肺动脉高压(PH)发挥保护作用仍有待阐明,肺动脉高压是心血管医学中一种致命的疾病。
采用缺氧诱导的小鼠肺动脉高压模型进行研究。在暴露于缺氧3周后,我们评估了非红系谱系中缺乏促红细胞生成素受体(EpoR)的小鼠(EpoR(-/-)挽救小鼠)的右心室收缩压、右心室肥厚和肺血管重塑。这些小鼠在心血管系统中缺乏EpoR,但在造血系统中不缺乏。与野生型小鼠相比,EpoR(-/-)挽救小鼠的肺动脉高压和肺血管重塑进展加快。EpoR(-/-)挽救小鼠中EPCs的动员及其向肺内皮的募集明显受损。相比之下,用野生型骨髓细胞重建骨髓可改善EpoR(-/-)挽救小鼠的肺动脉高压。缺氧增强了野生型小鼠而非EpoR(-/-)挽救小鼠肺内皮细胞上EpoR的表达。最后,缺氧激活了野生型小鼠肺中的内皮型一氧化氮合酶,但未激活EpoR(-/-)挽救小鼠肺中的内皮型一氧化氮合酶。
这些结果表明,内源性Epo/EpoR系统在EPCs募集中起重要作用,并在体内小鼠慢性缺氧期间预防肺动脉高压的发生,提示该系统对肺动脉高压治疗具有重要的治疗意义。